Clinical Focus

• Neurological Surgery
• Neurosurgery
• Brain/Central Nervous System Cancer
• Stereotactic Radiosurgery

Administrative Appointments

• Founder and Member of the Board of Directors, Accuray, Inc. (1991 - 2009)
• President, Cyberknife Society (2003 - 2008)
• Vice President, Western Neurosurgical Society (2005 - 2006)
• Chairman, Accuray, Inc. (1999 - 2004)
• CEO, Accuray, Inc. (1999 - 2002)

Honors and Awards

• The Inaugural Ideals of Entepreneurship Award, Emerging Entepreneurs in Biomedical Technology, Biodesign Group, Stanford University (2005)
• Outstanding Achievement in Medicine, Santa Clara Valley Medical Association (2007)

Professional Education

Graduate & Fellowship Program Affiliations

• Neurosurgery

Industry Relationships

Stanford is committed to ethical and transparent interactions with our industrial and other commercial partners. It is our policy to disclose payments (exclusive of travel support) from, and/or equity in, companies or other commercial entities to Stanford faculty of $5,000 or more in total value, as well as any equity in a privately held company, when the faculty member also has institutional responsibilities related to his or her interactions with the company. View Full Information

Current Research Interests

The development and implementation of computerized, image-guided surgical tools to be utilized during minimally invasive brain operations. The clinical outcome of new technologies, and in particular the application of radiosurgery, for the treatment of brain tumors. The creation of new radiosurgical techniques for a wide array of brain and spine disorders which includes 1) trigeminal neuralgia 2) spinal cord AVM 3) pituitary tumors 4) skull base meningioma 5) benign peri-optic tumors 6) brain metastases 7) acoustic neuroma 8) glomus jugulare tumors 9) brain and spine schwannoma 10) painful facet syndrome 11) radiomodulation for functional disease of the brain

Clinical Trials

• Phase I/II Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases Recruiting
• Radiosurgical Neuromodulation for Refractory Depression Enrolling by Invitation

Publications

• Cochlea Radiation Dose Correlates with Hearing Loss Following Stereotactic Radiosurgery of Vestibular Schwannoma. Hayden MG, Hansasuta A, Balise RR, Choi C, Sakamoto GT, Venteicher AS, Soltys SG, Gibbs IC, Harsh GR, Adler JR, Chang SD. World Neurosurg. 2012
• What Is the Optimal Treatment of Large Brain Metastases? An Argument for a Multidisciplinary Approach. Choi CY, Chang SD, Gibbs IC, Adler JR, Harsh GR, Atalar B, Lieberson RE, Soltys SG. Int J Radiat Oncol Biol Phys. 2012
• Management of pediatric intracranial arteriovenous malformations: experience with multimodality therapy. Darsaut TE, Guzman R, Marcellus ML, Edwards MS, Tian L, Do HM, Chang SD, Levy RP, Adler JR, Marks MP, Steinberg GK. Neurosurgery. 2011; 69 (3): 540-56; discussion 556
• Multisession stereotactic radiosurgery for vestibular schwannomas: single-institution experience with 383 cases. Hansasuta A, Choi CY, Gibbs IC, Soltys SG, Tse VC, Lieberson RE, Hayden MG, Sakamoto GT, Harsh GR, Adler JR, Chang SD. Neurosurgery. 2011; 69 (6): 1200-9
• Normal Tissue Complication Probability Estimation by the Lyman-Kutcher-Burman Method Does Not Accurately Predict Spinal Cord Tolerance to Stereotactic Radiosurgery. Daly ME, Luxton G, Choi CY, Gibbs IC, Chang SD, Adler JR, Soltys SG. Int J Radiat Oncol Biol Phys. 2011